Kainos Medicine Inc
284620
Company Profile
Business description
Kainos Medicine Inc conducts research and develops medicines used to treat brain diseases, cancers, and infectious diseases.
Contact
16, Daewangpangyo-ro 712 beon-gil
4th Floor, Institut Pasteur Korea
Bundang-gu, Gyeonggi-do
Seongnam-si13488
KORT: +82 25677419
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
19
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,959.70 | 106.00 | 1.35% |
| CAC 40 | 7,273.12 | 168.32 | 2.37% |
| DAX 40 | 20,906.79 | 532.69 | 2.61% |
| Dow JONES (US) | 40,301.60 | 88.89 | 0.22% |
| FTSE 100 | 8,134.34 | 170.16 | 2.14% |
| HKSE | 21,417.40 | 502.71 | 2.40% |
| NASDAQ | 16,734.98 | 10.53 | 0.06% |
| Nikkei 225 | 33,982.36 | 396.78 | 1.18% |
| NZX 50 Index | 12,107.54 | 88.41 | 0.74% |
| S&P 500 | 5,378.40 | 15.04 | 0.28% |
| S&P/ASX 200 | 7,748.60 | 102.10 | 1.34% |
| SSE Composite Index | 3,262.81 | 24.58 | 0.76% |